I am an Indian-American scientist interested in discovery and development of novel biotherapeutics that benefit the patients with unmet medical needs. I am passionate about using science and technology to mitigate challenges towards bringing biotherapeutics to market faster, more often, and at affordable costs. I am using my expertise in computational biology, bioinformatics, computational biophysics, and data science to promote biopharmaceutical informatics, in silico developability assessments, and digital transformation in Biopharmaceutical Industry. In particular, I have come up with a strategic vision, Biopharmaceutical Informatics. Biopharmaceutical Informatics calls for syncretic use of Computational Biophysics, Biomolecular experiments, Information technology, and AIML towards improving the productivity of biologic drug discovery and development projects. In recent years, Biopharmaceutical Informatics has emerged as a field on its own. I have so far contributed more than 100 publications that have received more >11500 citations (h-index = 48; i10-index = 88; 26 cited >100 times and 1 with >1100 citations) and edited one book entitled "Developability of Biotherapeutics: Computational Approaches" (Please see featured weblinks for more information). I have recently finished editing another one entitled "Biopharmaceutical Informatics: Learning how to discover developable biotherapeutics". This book is currently in production. I have mentored numerous graduate students, postdoctoral fellows, and colleagues in biopharmaceutical industry. I am also experienced at recruiting, supervising, and nurturing talent. I am particularly adept at leading cross-functional and international teams and forging academic-industry collaborations.I am an associate Editor for mAbs, a Taylor & Francis Journal and a frequently invited speaker at the conferences in biopharmaceutical industry.In summary my professional experience, since completing doctorate, consists of approximately 27 years in Government, Academia and Industry.